Ocaro Pharmaceuticals
Greensboro, US
Biotech
Founders & leadership
RJ
Roland JohnsonExecutive Officer, Director
LS
Lanty SmithDirector
BY
Bill YatesDirector
EB
Eric BarnettExecutive Officer
AJ
Andy JaneDirector
Reported raises · per SEC filings
Form D private placements▶$610KraisedNov 2022 · 12 investors · PharmaceuticalsRule 506(b)
▶$610KraisedNov 2022 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Roland JohnsonExecutive Officer, Director
- Lanty SmithDirector
- Bill YatesDirector
- Eric BarnettExecutive Officer
- Andy JaneDirector
- Offering amount
- $610K
- Amount sold
- $610K
- Minimum investment
- $30K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.